ERCC5_HUMAN - dbPTM
ERCC5_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ERCC5_HUMAN
UniProt AC P28715
Protein Name DNA repair protein complementing XP-G cells
Gene Name ERCC5
Organism Homo sapiens (Human).
Sequence Length 1186
Subcellular Localization Nucleus .
Protein Description Single-stranded structure-specific DNA endonuclease involved in DNA excision repair. Makes the 3'incision in DNA nucleotide excision repair (NER). Acts as a cofactor for a DNA glycosylase that removes oxidized pyrimidines from DNA. May also be involved in transcription-coupled repair of this kind of damage, in transcription by RNA polymerase II, and perhaps in other processes too..
Protein Sequence MGVQGLWKLLECSGRQVSPEALEGKILAVDISIWLNQALKGVRDRHGNSIENPHLLTLFHRLCKLLFFRIRPIFVFDGDAPLLKKQTLVKRRQRKDLASSDSRKTTEKLLKTFLKRQAIKTAFRSKRDEALPSLTQVRRENDLYVLPPLQEEEKHSSEEEDEKEWQERMNQKQALQEEFFHNPQAIDIESEDFSSLPPEVKHEILTDMKEFTKRRRTLFEAMPEESDDFSQYQLKGLLKKNYLNQHIEHVQKEMNQQHSGHIRRQYEDEGGFLKEVESRRVVSEDTSHYILIKGIQAKTVAEVDSESLPSSSKMHGMSFDVKSSPCEKLKTEKEPDATPPSPRTLLAMQAALLGSSSEEELESENRRQARGRNAPAAVDEGSISPRTLSAIKRALDDDEDVKVCAGDDVQTGGPGAEEMRINSSTENSDEGLKVRDGKGIPFTATLASSSVNSAEEHVASTNEGREPTDSVPKEQMSLVHVGTEAFPISDESMIKDRKDRLPLESAVVRHSDAPGLPNGRELTPASPTCTNSVSKNETHAEVLEQQNELCPYESKFDSSLLSSDDETKCKPNSASEVIGPVSLQETSSIVSVPSEAVDNVENVVSFNAKEHENFLETIQEQQTTESAGQDLISIPKAVEPMEIDSEESESDGSFIEVQSVISDEELQAEFPETSKPPSEQGEEELVGTREGEAPAESESLLRDNSERDDVDGEPQEAEKDAEDSLHEWQDINLEELETLESNLLAQQNSLKAQKQQQERIAATVTGQMFLESQELLRLFGIPYIQAPMEAEAQCAILDLTDQTSGTITDDSDIWLFGARHVYRNFFNKNKFVEYYQYVDFHNQLGLDRNKLINLAYLLGSDYTEGIPTVGCVTAMEILNEFPGHGLEPLLKFSEWWHEAQKNPKIRPNPHDTKVKKKLRTLQLTPGFPNPAVAEAYLKPVVDDSKGSFLWGKPDLDKIREFCQRYFGWNRTKTDESLFPVLKQLDAQQTQLRIDSFFRLAQQEKEDAKRIKSQRLNRAVTCMLRKEKEAAASEIEAVSVAMEKEFELLDKAKGKTQKRGITNTLEESSSLKRKRLSDSKGKNTCGGFLGETCLSESSDGSSSEDAESSSLMNVQRRTAAKEPKTSASDSQNSVKEAPVKNGGATTSSSSDSDDDGGKEKMVLVTARSVFGKKRRKLRRARGRKRKT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
8AcetylationMGVQGLWKLLECSGR
CCHHHHHHHHHCCCC
48.5119608861
8UbiquitinationMGVQGLWKLLECSGR
CCHHHHHHHHHCCCC
48.5119608861
64AcetylationTLFHRLCKLLFFRIR
HHHHHHHHHHHHHCC
53.4625953088
64UbiquitinationTLFHRLCKLLFFRIR
HHHHHHHHHHHHHCC
53.4623000965
85UbiquitinationGDAPLLKKQTLVKRR
CCCCHHHHHHHHHHH
48.78-
99PhosphorylationRQRKDLASSDSRKTT
HHHHHHCCCCCHHHH
41.8120068231
100PhosphorylationQRKDLASSDSRKTTE
HHHHHCCCCCHHHHH
33.7220068231
102PhosphorylationKDLASSDSRKTTEKL
HHHCCCCCHHHHHHH
37.3120873877
106PhosphorylationSSDSRKTTEKLLKTF
CCCCHHHHHHHHHHH
33.8730576142
111UbiquitinationKTTEKLLKTFLKRQA
HHHHHHHHHHHHHHH
47.90-
120UbiquitinationFLKRQAIKTAFRSKR
HHHHHHHHHHHHHHH
36.4929967540
121PhosphorylationLKRQAIKTAFRSKRD
HHHHHHHHHHHHHHH
25.5621964256
126UbiquitinationIKTAFRSKRDEALPS
HHHHHHHHHHHCCCC
60.6629967540
133PhosphorylationKRDEALPSLTQVRRE
HHHHCCCCCCCCCCC
44.9228555341
144PhosphorylationVRRENDLYVLPPLQE
CCCCCCEEEECCCCH
11.6422496350
156PhosphorylationLQEEEKHSSEEEDEK
CCHHHCCCCHHHHHH
50.9823927012
157PhosphorylationQEEEKHSSEEEDEKE
CHHHCCCCHHHHHHH
49.0725159151
172UbiquitinationWQERMNQKQALQEEF
HHHHHHHHHHHHHHH
32.3129967540
209UbiquitinationHEILTDMKEFTKRRR
HHHHHCHHHHHHHHH
53.1129967540
213UbiquitinationTDMKEFTKRRRTLFE
HCHHHHHHHHHHHHH
49.59-
217PhosphorylationEFTKRRRTLFEAMPE
HHHHHHHHHHHHCCC
33.7128122231
235UbiquitinationDFSQYQLKGLLKKNY
CCHHHHHHHHHHHHH
31.8029967540
240UbiquitinationQLKGLLKKNYLNQHI
HHHHHHHHHHHHHHH
51.2829967540
252UbiquitinationQHIEHVQKEMNQQHS
HHHHHHHHHHHHHCC
58.8229967540
274UbiquitinationEDEGGFLKEVESRRV
ECCCCCCHHHHHCEE
58.4129967540
287O-linked_GlycosylationRVVSEDTSHYILIKG
EEECCCCCEEEEEEC
26.9830379171
287PhosphorylationRVVSEDTSHYILIKG
EEECCCCCEEEEEEC
26.9825003641
289PhosphorylationVSEDTSHYILIKGIQ
ECCCCCEEEEEECCE
9.3728796482
293UbiquitinationTSHYILIKGIQAKTV
CCEEEEEECCEEEEE
46.6621890473
293 (in isoform 1)Ubiquitination-46.6621890473
293UbiquitinationTSHYILIKGIQAKTV
CCEEEEEECCEEEEE
46.6621890473
298UbiquitinationLIKGIQAKTVAEVDS
EEECCEEEEEEEECC
27.4429967540
305PhosphorylationKTVAEVDSESLPSSS
EEEEEECCCCCCCCC
33.9727251275
307PhosphorylationVAEVDSESLPSSSKM
EEEECCCCCCCCCHH
49.9221815630
310O-linked_GlycosylationVDSESLPSSSKMHGM
ECCCCCCCCCHHCCC
53.1630379171
310PhosphorylationVDSESLPSSSKMHGM
ECCCCCCCCCHHCCC
53.1621815630
311PhosphorylationDSESLPSSSKMHGMS
CCCCCCCCCHHCCCC
31.8525159151
312PhosphorylationSESLPSSSKMHGMSF
CCCCCCCCHHCCCCE
38.0321815630
313AcetylationESLPSSSKMHGMSFD
CCCCCCCHHCCCCEE
36.5425953088
313UbiquitinationESLPSSSKMHGMSFD
CCCCCCCHHCCCCEE
36.5429967540
318PhosphorylationSSKMHGMSFDVKSSP
CCHHCCCCEECCCCH
23.9225159151
322UbiquitinationHGMSFDVKSSPCEKL
CCCCEECCCCHHHHC
47.2429967540
323PhosphorylationGMSFDVKSSPCEKLK
CCCEECCCCHHHHCC
39.0828450419
324PhosphorylationMSFDVKSSPCEKLKT
CCEECCCCHHHHCCC
28.0527422710
331PhosphorylationSPCEKLKTEKEPDAT
CHHHHCCCCCCCCCC
63.8323927012
338PhosphorylationTEKEPDATPPSPRTL
CCCCCCCCCCCHHHH
43.0129255136
341PhosphorylationEPDATPPSPRTLLAM
CCCCCCCCHHHHHHH
28.3729255136
344PhosphorylationATPPSPRTLLAMQAA
CCCCCHHHHHHHHHH
29.5226074081
355PhosphorylationMQAALLGSSSEEELE
HHHHHHCCCCHHHHH
30.5721955146
356PhosphorylationQAALLGSSSEEELES
HHHHHCCCCHHHHHH
39.7121955146
357PhosphorylationAALLGSSSEEELESE
HHHHCCCCHHHHHHH
51.2121955146
363PhosphorylationSSEEELESENRRQAR
CCHHHHHHHHHHHHC
53.4420363803
382PhosphorylationPAAVDEGSISPRTLS
CCCCCCCCCCHHHHH
20.1829255136
384PhosphorylationAVDEGSISPRTLSAI
CCCCCCCCHHHHHHH
15.2719664994
387PhosphorylationEGSISPRTLSAIKRA
CCCCCHHHHHHHHHH
28.5726074081
389PhosphorylationSISPRTLSAIKRALD
CCCHHHHHHHHHHCC
27.6025159151
392AcetylationPRTLSAIKRALDDDE
HHHHHHHHHHCCCCC
31.1925953088
392UbiquitinationPRTLSAIKRALDDDE
HHHHHHHHHHCCCCC
31.1929967540
402UbiquitinationLDDDEDVKVCAGDDV
CCCCCCCEEECCCCC
43.8721963094
423PhosphorylationAEEMRINSSTENSDE
CCEECCCCCCCCCCC
35.9425159151
424PhosphorylationEEMRINSSTENSDEG
CEECCCCCCCCCCCC
34.9425159151
425PhosphorylationEMRINSSTENSDEGL
EECCCCCCCCCCCCC
38.7221712546
428PhosphorylationINSSTENSDEGLKVR
CCCCCCCCCCCCCCC
30.7025159151
433UbiquitinationENSDEGLKVRDGKGI
CCCCCCCCCCCCCCC
46.1933845483
438AcetylationGLKVRDGKGIPFTAT
CCCCCCCCCCCCEEE
58.9425953088
477PhosphorylationSVPKEQMSLVHVGTE
CCCHHHHCEEEECCC
27.2528555341
489PhosphorylationGTEAFPISDESMIKD
CCCEECCCCHHHCCC
35.2528555341
511PhosphorylationESAVVRHSDAPGLPN
CHHEECCCCCCCCCC
25.5528555341
523PhosphorylationLPNGRELTPASPTCT
CCCCCEECCCCCCCC
16.4430266825
526PhosphorylationGRELTPASPTCTNSV
CCEECCCCCCCCCCC
23.1919664994
528PhosphorylationELTPASPTCTNSVSK
EECCCCCCCCCCCCC
29.4830266825
530PhosphorylationTPASPTCTNSVSKNE
CCCCCCCCCCCCCCH
32.7630266825
532PhosphorylationASPTCTNSVSKNETH
CCCCCCCCCCCCHHH
15.0430278072
534PhosphorylationPTCTNSVSKNETHAE
CCCCCCCCCCHHHHH
29.5923927012
538PhosphorylationNSVSKNETHAEVLEQ
CCCCCCHHHHHHHHH
35.4622210691
552PhosphorylationQQNELCPYESKFDSS
HHHCCCCCCCCCCHH
31.6627732954
554PhosphorylationNELCPYESKFDSSLL
HCCCCCCCCCCHHHC
32.5526074081
558PhosphorylationPYESKFDSSLLSSDD
CCCCCCCHHHCCCCC
26.4730266825
559PhosphorylationYESKFDSSLLSSDDE
CCCCCCHHHCCCCCC
34.8630266825
562PhosphorylationKFDSSLLSSDDETKC
CCCHHHCCCCCCCCC
36.6929255136
563PhosphorylationFDSSLLSSDDETKCK
CCHHHCCCCCCCCCC
49.3929255136
567PhosphorylationLLSSDDETKCKPNSA
HCCCCCCCCCCCCCH
49.0529255136
573PhosphorylationETKCKPNSASEVIGP
CCCCCCCCHHHCCCC
41.5226074081
575PhosphorylationKCKPNSASEVIGPVS
CCCCCCHHHCCCCCC
32.0226074081
605PhosphorylationDNVENVVSFNAKEHE
CCCCCEECCCHHHHH
14.4324719451
662PhosphorylationIEVQSVISDEELQAE
EEEEEEECCHHHHHH
36.4922817901
678PhosphorylationPETSKPPSEQGEEEL
CCCCCCCHHHCCCCC
51.5922817901
697PhosphorylationEGEAPAESESLLRDN
CCCCCCCCHHHHCCC
34.2925850435
699PhosphorylationEAPAESESLLRDNSE
CCCCCCHHHHCCCCC
41.8221815630
705PhosphorylationESLLRDNSERDDVDG
HHHHCCCCCCCCCCC
37.9930576142
724PhosphorylationAEKDAEDSLHEWQDI
HHHHHHHHHHHHHCC
24.1125159151
738PhosphorylationINLEELETLESNLLA
CCHHHHHHHHHHHHH
48.7420068231
741PhosphorylationEELETLESNLLAQQN
HHHHHHHHHHHHHHH
35.5720068231
749PhosphorylationNLLAQQNSLKAQKQQ
HHHHHHHHHHHHHHH
27.2320068231
751UbiquitinationLAQQNSLKAQKQQQE
HHHHHHHHHHHHHHH
48.9029967540
830UbiquitinationRNFFNKNKFVEYYQY
HHCCCCCCCEEEEEE
53.01-
904UbiquitinationHEAQKNPKIRPNPHD
HHHHHCCCCCCCCCC
61.8229967540
920PhosphorylationKVKKKLRTLQLTPGF
HHHHHHCCCCCCCCC
29.3220068231
924PhosphorylationKLRTLQLTPGFPNPA
HHCCCCCCCCCCCHH
14.3820068231
936PhosphorylationNPAVAEAYLKPVVDD
CHHHHHHHHCCEEEC
13.5320068231
952UbiquitinationKGSFLWGKPDLDKIR
CCCCCCCCCCHHHHH
24.6329967540
971PhosphorylationRYFGWNRTKTDESLF
HHHCCCCCCCCCHHH
34.7723403867
972UbiquitinationYFGWNRTKTDESLFP
HHCCCCCCCCCHHHH
51.2229967540
973PhosphorylationFGWNRTKTDESLFPV
HCCCCCCCCCHHHHH
44.3723403867
976PhosphorylationNRTKTDESLFPVLKQ
CCCCCCCHHHHHHHH
37.8123403867
982UbiquitinationESLFPVLKQLDAQQT
CHHHHHHHHHCHHHH
49.3929967540
995PhosphorylationQTQLRIDSFFRLAQQ
HHHHHHHHHHHHHHH
24.7424719451
1004UbiquitinationFRLAQQEKEDAKRIK
HHHHHHHHHHHHHHH
57.4624816145
1012PhosphorylationEDAKRIKSQRLNRAV
HHHHHHHHHHHHHHH
20.4024719451
1020PhosphorylationQRLNRAVTCMLRKEK
HHHHHHHHHHHHHHH
7.3924719451
1032PhosphorylationKEKEAAASEIEAVSV
HHHHHHHHHHHHHHH
34.0930576142
1050AcetylationKEFELLDKAKGKTQK
HHHHHHHHHCCCCCC
52.5525953088
1050UbiquitinationKEFELLDKAKGKTQK
HHHHHHHHHCCCCCC
52.55-
1063PhosphorylationQKRGITNTLEESSSL
CCCCCCCHHHHCCHH
27.2228555341
1067PhosphorylationITNTLEESSSLKRKR
CCCHHHHCCHHCHHH
18.8223401153
1068PhosphorylationTNTLEESSSLKRKRL
CCHHHHCCHHCHHHC
42.8630576142
1069PhosphorylationNTLEESSSLKRKRLS
CHHHHCCHHCHHHCC
47.3825159151
1071MethylationLEESSSLKRKRLSDS
HHHCCHHCHHHCCCC
58.80115978467
1071UbiquitinationLEESSSLKRKRLSDS
HHHCCHHCHHHCCCC
58.80-
1124PhosphorylationTAAKEPKTSASDSQN
HHCCCCCCCCCCCCC
39.9927794612
1125PhosphorylationAAKEPKTSASDSQNS
HCCCCCCCCCCCCCC
31.7227794612
1127PhosphorylationKEPKTSASDSQNSVK
CCCCCCCCCCCCCCC
37.2527794612
1129PhosphorylationPKTSASDSQNSVKEA
CCCCCCCCCCCCCCC
28.8521712546
1132PhosphorylationSASDSQNSVKEAPVK
CCCCCCCCCCCCCCC
27.2521712546
1139AcetylationSVKEAPVKNGGATTS
CCCCCCCCCCCCCCC
49.147711251
1145PhosphorylationVKNGGATTSSSSDSD
CCCCCCCCCCCCCCC
26.52-
1147PhosphorylationNGGATTSSSSDSDDD
CCCCCCCCCCCCCCC
31.59-
1148PhosphorylationGGATTSSSSDSDDDG
CCCCCCCCCCCCCCC
37.62-
1149PhosphorylationGATTSSSSDSDDDGG
CCCCCCCCCCCCCCC
42.98-
1151PhosphorylationTTSSSSDSDDDGGKE
CCCCCCCCCCCCCCE
44.91-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseDTLQ9NZJ0
PMID:25483071

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ERCC5_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ERCC5_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PCNA_HUMANPCNAphysical
9305916
ERCC2_HUMANERCC2physical
8652557
EWS_HUMANEWSR1physical
16713569
RPB1_HUMANPOLR2Aphysical
16246722
ERCC6_HUMANERCC6physical
16246722
DTL_HUMANDTLphysical
25483071
BRCA2_HUMANBRCA2physical
26833090
PALB2_HUMANPALB2physical
26833090
RAD51_HUMANRAD51physical
26833090
BRCA1_HUMANBRCA1physical
26833090

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
278780Xeroderma pigmentosum complementation group G (XP-G)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ERCC5_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384; SER-559; SER-562AND SER-563, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384; SER-526; SER-562AND SER-563, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-157; THR-338;SER-341; SER-355; SER-356; SER-357; SER-382; SER-384; SER-423;SER-424; SER-428; SER-559; SER-562 AND SER-563, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384 AND SER-526, ANDMASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384 AND SER-526, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-157; SER-355;SER-356; SER-357; SER-384 AND SER-724, AND MASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-338; SER-341; SER-355;SER-356; SER-357; SER-384; SER-428; SER-526 AND SER-563, AND MASSSPECTROMETRY.

TOP